ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

14 links2 made here, not in the record25 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT04632992A Study Evaluating TargetedTherapies in ParticipantsWho Have Advanced SolidTumors With GenomicAlterations or ProteinExpression PatternsPredictive of ResponseGenentech, Inc.Phase 2 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSAdvanced Unresectable or Me…No longer in the registry's filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseDRUGSEntrectinibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedInavolisibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAlectinibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedIpatasertibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAtezolizumabIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAdo-Trastuzumab EmtansineEntry “Trastuzumab Emtansine”, read b…›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPertuzumab/Trastuzumab/Hyal…Entry “Pertuzumab, Trastuzumab, and H…›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTucatinibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPaclitaxelIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTiragolumabIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPralsetinibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTrastuzumabMade here · Found by reading; no entr…›Nov 2 · Claude Opus 5.5 · TestedTestedPertuzumabMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Entrectinib

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Entrectinib”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2Trastuzumabmade hereClaude Opus 5.5TestedCurrent
Nov 3EntrectinibClaude Opus 5.5TestedCurrent
Nov 3InavolisibClaude Opus 5.5TestedCurrent
Nov 3AlectinibClaude Opus 5.5TestedCurrent
Nov 3IpatasertibClaude Opus 5.5TestedCurrent
Nov 3AtezolizumabClaude Opus 5.5TestedCurrent
Nov 3Ado-Trastuzumab EmtansineClaude Opus 5.5TestedCurrent
Nov 3Pertuzumab/Trastuzumab/Hyaluronidase-zzxfClaude Opus 5.5TestedCurrent
Nov 3TucatinibClaude Opus 5.5TestedCurrent
Nov 3PaclitaxelClaude Opus 5.5TestedCurrent
Nov 3TiragolumabClaude Opus 5.5TestedCurrent
Nov 3PralsetinibClaude Opus 5.5TestedCurrent
Nov 3Pertuzumabmade hereClaude Opus 5.5TestedCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 14Advanced Unresectable or Metastatic Solid MalignancyRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 18EntrectinibRule based · role ruleTestedAgrees
Nov 18InavolisibRule based · role ruleTestedAgrees
Nov 18AlectinibRule based · role ruleTestedAgrees
Nov 18IpatasertibRule based · role ruleTestedAgrees
Nov 18AtezolizumabRule based · role ruleTestedAgrees
Nov 18Ado-Trastuzumab EmtansineRule based · role ruleTestedAgrees
Nov 18Pertuzumab/Trastuzumab/Hyaluronidase-zzxfRule based · role ruleTestedAgrees
Nov 18TucatinibRule based · role ruleTestedAgrees
Nov 18PaclitaxelRule based · role ruleTestedAgrees
Nov 18TiragolumabRule based · role ruleTestedAgrees
Nov 18PralsetinibRule based · role ruleTestedAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.